Comments
Loading...

I-MAB

IMABNASDAQ
$1.63
00.00%
At Close: -
$1.68
0.053.07%
After Hours: Jul 15, 9:03 AM EDT
15 minutes delayed
Consensus Rating1
Overweight
Highest Price Target1
$25.00
Lowest Price Target1
$6.00
Consensus Price Target1
$12.25

want to know what
the Bulls & Bears Say?

I-MAB (NASDAQ:IMAB) Stock, Analyst Ratings, Price Targets, Forecasts

I-MAB has a consensus price target of $12.25 based on the ratings of 4 analysts. The high is $25 issued by Cantor Fitzgerald on September 5, 2023. The low is $6 issued by Needham on April 12, 2024. The 3 most-recent analyst ratings were released by Needham, Piper Sandler, and HC Wainwright & Co. on April 12, 2024, March 18, 2024, and March 18, 2024, respectively. With an average price target of $8 between Needham, Piper Sandler, and HC Wainwright & Co., there's an implied 376.19% upside for I-MAB from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Feb
1
Mar
0
0
0
0
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
Piper Sandler
HC Wainwright & Co.
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for I-MAB

Buy NowGet Alert
04/12/2024Buy Now257.14%Needham
Gil Blum
→ $6ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now495.24%Piper Sandler
Joseph Catanzaro
$15 → $10MaintainsOverweightGet Alert
03/18/2024Buy Now376.19%HC Wainwright & Co.
Andrew Fein
$18 → $8ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now257.14%Needham
Gil Blum
$8 → $6MaintainsBuyGet Alert
02/08/2024Buy Now376.19%Needham
Gil Blum
$23 → $8MaintainsBuyGet Alert
09/25/2023Buy Now1269.05%Needham
Gil Blum
$24 → $23MaintainsBuyGet Alert
09/05/2023Buy Now1388.1%Cantor Fitzgerald
Louise Chen
→ $25ReiteratesOverweight → OverweightGet Alert
08/18/2023Buy Now1388.1%Cantor Fitzgerald
Louise Chen
→ $25ReiteratesOverweight → OverweightGet Alert
08/18/2023Buy Now971.43%HC Wainwright & Co.
Andrew Fein
$25 → $18MaintainsBuyGet Alert
08/18/2023Buy Now1328.57%Needham
Gil Blum
→ $24ReiteratesBuy → BuyGet Alert
06/05/2023Buy Now1328.57%Needham
Gil Blum
→ $24ReiteratesBuy → BuyGet Alert
04/19/2023Buy Now1328.57%Needham
Gil Blum
→ $24Reiterates → BuyGet Alert
04/03/2023Buy Now1328.57%Needham
Gil Blum
$33 → $24MaintainsBuyGet Alert
04/03/2023Buy Now1388.1%Piper Sandler
Joseph Catanzaro
$30 → $25MaintainsOverweightGet Alert
04/03/2023Buy Now1388.1%HC Wainwright & Co.
Andrew Fein
$45 → $25MaintainsBuyGet Alert
08/31/2022Buy Now2578.57%HC Wainwright & Co.
Andrew Fein
$70 → $45MaintainsBuyGet Alert
08/31/2022Buy Now1864.29%Needham
Gil Blum
$41 → $33MaintainsBuyGet Alert
08/30/2022Buy Now1685.71%Piper Sandler
Joseph Catanzaro
$35 → $30MaintainsOverweightGet Alert
08/17/2022Buy Now2340.48%Needham
Gil Blum
$72 → $41MaintainsBuyGet Alert
05/31/2022Buy Now4066.67%HC Wainwright & Co.
Andrew Fein
$80 → $70MaintainsBuyGet Alert
05/31/2022Buy Now4185.71%Needham
Gil Blum
$85 → $72MaintainsBuyGet Alert
03/30/2022Buy Now4661.9%HC Wainwright & Co.
Andrew Fein
$95 → $80MaintainsBuyGet Alert
11/01/2021Buy Now4959.52%Needham
Gil Blum
MaintainsBuyGet Alert
09/01/2021Buy Now5554.76%HC Wainwright & Co.
Andrew Fein
MaintainsBuyGet Alert

FAQ

Q

What is the target price for I-MAB (IMAB) stock?

A

The latest price target for I-MAB (NASDAQ:IMAB) was reported by Needham on April 12, 2024. The analyst firm set a price target for $6.00 expecting IMAB to rise to within 12 months (a possible 257.14% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for I-MAB (IMAB)?

A

The latest analyst rating for I-MAB (NASDAQ:IMAB) was provided by Needham, and I-MAB reiterated their buy rating.

Q

When was the last upgrade for I-MAB (IMAB)?

A

There is no last upgrade for I-MAB

Q

When was the last downgrade for I-MAB (IMAB)?

A

There is no last downgrade for I-MAB.

Q

When is the next analyst rating going to be posted or updated for I-MAB (IMAB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of I-MAB, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for I-MAB was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.

Q

Is the Analyst Rating I-MAB (IMAB) correct?

A

While ratings are subjective and will change, the latest I-MAB (IMAB) rating was a reiterated with a price target of $6.00 to $6.00. The current price I-MAB (IMAB) is trading at is $1.68, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch